Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 12, 2020

SELL
$7.35 - $10.81 $61,512 - $90,468
-8,369 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$8.38 - $17.34 $109,409 - $226,391
-13,056 Reduced 60.94%
8,369 $87,000
Q4 2019

Feb 14, 2020

SELL
$11.18 - $18.6 $83,682 - $139,221
-7,485 Reduced 25.89%
21,425 $383,000
Q3 2019

Nov 14, 2019

SELL
$12.09 - $20.46 $526,531 - $891,053
-43,551 Reduced 60.1%
28,910 $361,000
Q2 2019

Aug 14, 2019

SELL
$18.5 - $25.47 $747,622 - $1.03 Million
-40,412 Reduced 35.8%
72,461 $1.44 Million
Q1 2019

May 15, 2019

SELL
$14.62 - $22.13 $435,646 - $659,429
-29,798 Reduced 20.89%
112,873 $2.38 Million
Q4 2018

Jan 31, 2019

SELL
$17.09 - $38.25 $464,352 - $1.04 Million
-27,171 Reduced 16.0%
142,671 $2.92 Million
Q3 2018

Nov 15, 2018

BUY
$34.05 - $55.9 $362,802 - $595,614
10,655 Added 6.69%
169,842 $6.26 Million
Q2 2018

Aug 22, 2018

BUY
$36.15 - $52.5 $1.88 Million - $2.73 Million
52,045 Added 48.58%
159,187 $8 Million
Q2 2018

Aug 15, 2018

BUY
$36.15 - $52.5 $293,682 - $426,510
8,124 Added 8.2%
107,142 $8 Million
Q1 2018

May 15, 2018

BUY
$24.4 - $40.25 $372,636 - $614,698
15,272 Added 18.24%
99,018 $2.89 Million
Q4 2017

Feb 13, 2018

BUY
$18.5 - $28.6 $836,200 - $1.29 Million
45,200 Added 117.26%
83,746 $2.37 Million
Q3 2017

Nov 07, 2017

BUY
$14.65 - $19.35 $564,698 - $745,865
38,546
38,546 $746,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $534M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Advisors Asset Management, Inc. Portfolio

Follow Advisors Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.